These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis. Berglund L; Brunzell JD; Goldberg AC; Goldberg IJ; Stalenhoef A Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):423-37. PubMed ID: 24840268 [TBL] [Abstract][Full Text] [Related]
23. A physician's guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy. Klop B; Wouter Jukema J; Rabelink TJ; Castro Cabezas M Panminerva Med; 2012 Jun; 54(2):91-103. PubMed ID: 22525564 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of hypertriglyceridemia: plasma exchange]. Koike M; Nitta K Nihon Rinsho; 2013 Sep; 71(9):1667-9. PubMed ID: 24205732 [TBL] [Abstract][Full Text] [Related]
25. An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor? Chan DC; Chen MM; Ooi EM; Watts GF Int J Clin Pract; 2008 May; 62(5):799-809. PubMed ID: 18201179 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic pitfalls during therapy for extreme hypertriglyceridaemia. Orth M; Luley C Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):101-3. PubMed ID: 9056751 [TBL] [Abstract][Full Text] [Related]
27. [Hypertriglyceridemia--diagnostics, risk and treatment]. Hexeberg S; Retterstøl K Tidsskr Nor Laegeforen; 2004 Nov; 124(21):2746-9. PubMed ID: 15534665 [TBL] [Abstract][Full Text] [Related]
28. Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis. Alagozlu H; Cindoruk M; Unal S Clin Drug Investig; 2006; 26(5):297-302. PubMed ID: 17163263 [TBL] [Abstract][Full Text] [Related]
29. Hypertriglyceridaemia Induced Pancreatitis Management: A Case Report. Mufti AK; Ullah N; Hayat M; Khan MA J Pak Med Assoc; 2023 Sep; 73(9):1906-1908. PubMed ID: 37817711 [TBL] [Abstract][Full Text] [Related]
30. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100 [TBL] [Abstract][Full Text] [Related]
31. Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations. Hallén J; Sreeharan N Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):237-242. PubMed ID: 30060063 [TBL] [Abstract][Full Text] [Related]
32. Hypertriglyceridemia: impact and treatment. Goldberg IJ Endocrinol Metab Clin North Am; 2009 Mar; 38(1):137-49. PubMed ID: 19217516 [TBL] [Abstract][Full Text] [Related]
33. Management of severe hypertriglyceridaemia. Cybulska B; Kłosiewicz-Latoszek L Kardiol Pol; 2013; 71(10):1007-12. PubMed ID: 24197580 [TBL] [Abstract][Full Text] [Related]
34. Acute pancreatitis secondary to hypertriglyceridaemia caused by undiagnosed type 2 diabetes. Khaqan A; Munir A; Haider M J R Coll Physicians Edinb; 2021 Jun; 51(2):140-142. PubMed ID: 34131669 [TBL] [Abstract][Full Text] [Related]
35. Hypertriglyceridemia. Pejic RN; Lee DT J Am Board Fam Med; 2006; 19(3):310-6. PubMed ID: 16672684 [TBL] [Abstract][Full Text] [Related]
36. Severe hypertriglyceridaemia as a result of familial chylomicronaemia: the Cape Town experience. Pouwels ED; Blom DJ; Firth JC; Henderson HE; Marais AD S Afr Med J; 2008 Feb; 98(2):105-8. PubMed ID: 18350203 [TBL] [Abstract][Full Text] [Related]